- Email: [email protected]
Subject Index Volume 107 (2005)
Journal of Controlled Release 107 (2005) 579 – 581 www.elsevier.com/locate/jconrel
Subject Index Volume 107 (2005) A549 cells, (107) 30 Acoustic spectroscopy, (107) 253 Adjuvant, (107) 189 Adriamycin hydrochloride, (107) 513 Airborne pathogens, (107) 1 Alginate, (107) 395 Alzheimer’s disease, (107) 417 5-aminolevulinic acid, (107) 495 Amphiphile, (107) 502 Amphiphilic polymer, (107) 158 Antibacterial activity, (107) 174 Antibody conjugate, (107) 562 Anti-cancer activity, (107) 30 Antimicrobial peptide, (107) 122 Antiplaque agent, (107) 122 Antitumor efficacy, (107) 513 Apatite, (107) 463 Apoptosis, (107) 43 Aspect ratio, (107) 112 Bioavailability, (107) 215, (107) 523 Biodegradable microspheres, (107) 310 Biodegradable polyester, (107) 417 Biodegradable polymer, (107) 158 Biodegradable polymers, (107) 78 Biodistribution, (107) 215, (107) 262 Biomimetic, (107) 502 Blood–brain barrier (BBB), (107) 428 Bovine, (107) 189 Bovine serum albumin, (107) 158 Brain delivery, (107) 428 BSA, (107) 112 Caco-2, (107) 143 Calcium silicate, (107) 300 Calcium-deficient hydroxyapatite, (107) 112 Cancer, (107) 43 Catalase, (107) 65 Cationic bovine serum albumin (CBSA), (107) 428 Cationic lipid, (107) 276 Cationic liposome, (107) 373 Cationic steroids, (107) 174
doi:10.1016/S0168-3659(05)00461-X
Cationized gelatin microspheres, (107) 547 Cavitation, (107) 484 Cavitation events, (107) 253 Cell encapsulation, (107) 395 Cell viability, (107) 65 Cellular distribution, (107) 373 Cetyltrimethylammonium bromide, (107) 357 Chemical stability, (107) 495 Chewing gum, (107) 122 Cholesterol, (107) 502 Clay mineral, (107) 408 Clozapine, (107) 215 Coating material, (107) 343 Colloidal drug carriers, (107) 229 Composite film, (107) 343 Conjugation, (107) 43 Contrast variation, (107) 244 Controlled release, (107) 449, (107) 463, (107) 547 6-Coumarin, (107) 428 Crystallization in emulsions, (107) 229 Cubic gel, (107) 495 h-cyclodextrin, (107) 158 Cystic fibrosis, (107) 537 Cytokine delivery, (107) 189 Cytotoxicity, (107) 143 Degradable hydrogel, (107) 547 Delivery systems, (107) 1 Diabetes, (107) 65 Diffusion, (107) 320 Diffusion coefficient, (107) 97 Diffusion experiments, (107) 495 Disc formation, (107) 131 Dispersion stability, (107) 408 d,l-PLGA50, (107) 53 DNA transfection, (107) 97 DNA vaccine, (107) 357 DNA vaccines, (107) 1 Doxorubicin, (107) 253, (107) 262 Drug delivery, (107) 97, (107) 502 Drug delivery system, (107) 408 Drug release, (107) 320, (107) 513
580
Subject Index Volume 107 (2005)
Drug release mechanism, (107) 131 Drug-targeting, (107) 288 Dry emulsion, (107) 91 Emulsion solvent diffusion method, (107) 300 Enteric-coating, (107) 91 Facial amphiphiles, (107) 174 Finite dissolution rate, (107) 320 Floating controlled drug delivery system, (107) 300 Fludarabine, (107) 143 Fluorescence measurements, (107) 253 Folate vector, (107) 143 Fractal dimension, (107) 203 GelucireR, (107) 523 Gene delivery, (107) 547, (107) 562 Gene transfer, (107) 174 Genetic vaccination, (107) 449 Gentamicin, (107) 463 Glutamic acid decarboxylase, (107) 562 Grafted polymer, (107) 203 HBsAg, (107) 357 Hepatitis B virus, (107) 357 His-tag, (107) 97 Huperzine A, (107) 417 Immunogenicity, (107) 357 In vitro and in vivo release, (107) 122 In vitro controlled release, (107) 53 In vitro degradation, (107) 53 Inflammation, (107) 395 In-situ process, (107) 112 Interferon-gamma, (107) 189 Intracellular delivery, (107) 262 g-irradiation, (107) 78 Islet cell targeting, (107) 562 Isoniazid, (107) 288 Isopropyl myristate (IPM), (107) 30 Ketoprofen, (107) 395 Lactosylated polyethylenimine, (107) 537 Lateral phase separation, (107) 131 Lysolipid retention, (107) 131 Magnesium aluminum silicate, (107) 343 Mathematical model, (107) 320 Matrix systems, (107) 320 Matrix-in-cylinder system, (107) 523 MCF-7, (107) 143 Melittin, (107) 310 2-Methacryloyloxyethyl phosphorylcholine, (107) 502 Microcapsule, (107) 91 Microcomposite, (107) 343
Microencapsulation, (107) 449 Microparticle, (107) 288 Microsphere, (107) 53 Microspheres, (107) 65, (107) 78, (107) 300, (107) 417, (107) 463 Nanocapsules, (107) 244 Nano-carrier, (107) 112 Nanogel, (107) 143 Nanoparticles, (107) 158, (107) 203 NFnB, (107) 373 NFnB decoy, (107) 373 Non-viral gene delivery, (107) 449 Nucleoside 5V-triphosphate, (107) 143 Octreotide acetate, (107) 474 Oral protein delivery, (107) 91 Ovalbumin, (107) 78 Paclitaxel, (107) 30 PCL-b-d,l-PLGA50, (107) 53 Pegylated nanoparticle, (107) 428 Peptide release, (107) 474 Pharmacokinetics, (107) 215 Phase transition temperature and SNALP, (107) 276 PHBV, (107) 463 Plasmid DNA, (107) 547 PLGA nanoparticles, (107) 30 Pluronic micelles, (107) 253 Poly (lactide), (107) 474 Polycaprolactone, (107) 330 Poly(d,l-lactide), (107) 244 Polyesters, (107) 395 Poly(ethylene glycol), (107) 78, (107) 408 Polyethylene glycol, (107) 43 Polyethylenimine, (107) 537 Poly-(lactic/glycolic) acid, (107) 449 Polylactide, (107) 158 Poly(lactide-co-glycolide), (107) 78 Poly(lactide-co-glycolide-acid) microparticle, (107) 357 Polymorphic transitions, (107) 229 Porcine skin, (107) 495 Porosity, (107) 203 Propranolol, (107) 523 Protein crystallization, (107) 97 Protein delivery system, (107) 158 Protein pharmaceuticals, (107) 91 PRP, (107) 330 Pulmonary immunization, (107) 1 Recombinant bacterial vector, (107) 189 Release, (107) 203 Release behaviors, (107) 112 Repaglinide, (107) 300 RGD mimetic, (107) 262 RNA interference, (107) 276
Subject Index Volume 107 (2005) SANS, (107) 244 SBF, (107) 330 Shell thickness, (107) 244 siRNA delivery, (107) 276 Skin, (107) 484 Sodium alginate, (107) 343 Sodium lauryl sulfate, (107) 484 Solid lipid nanoparticles, (107) 215, (107) 229 Spray drying, (107) 417 Stability, (107) 122 Stereocomplex, (107) 474 Sterically stabilized liposomes, (107) 262 Superoxide dismutase, (107) 65 Sustained release, (107) 189, (107) 408, (107) 523 Sustained-release, (107) 288
Thermosensitive liposomes, (107) 131 TNFa, (107) 373 a-tocopheryl succinate, (107) 43 Transcription, (107) 537 Transdermal, (107) 484 Tricalcium phosphate, (107) 330 Triglycerides, (107) 229 Tuberculosis, (107) 288 Ultrasound, (107) 484 Unsaturated polyester, (107) 513 W1 / O / W2 emulsion-solvent evaporation technique, (107) 310 Wheat germ agglutinin (WGA), (107) 30 Wollastonite, (107) 463
581
Subject Index Volume 107 (2005) A549 cells, (107) 30 Acoustic spectroscopy, (107) 253 Adjuvant, (107) 189 Adriamycin hydrochloride, (107) 513 Airborne pathogens, (107) 1 Alginate, (107) 395 Alzheimer’s disease, (107) 417 5-aminolevulinic acid, (107) 495 Amphiphile, (107) 502 Amphiphilic polymer, (107) 158 Antibacterial activity, (107) 174 Antibody conjugate, (107) 562 Anti-cancer activity, (107) 30 Antimicrobial peptide, (107) 122 Antiplaque agent, (107) 122 Antitumor efficacy, (107) 513 Apatite, (107) 463 Apoptosis, (107) 43 Aspect ratio, (107) 112 Bioavailability, (107) 215, (107) 523 Biodegradable microspheres, (107) 310 Biodegradable polyester, (107) 417 Biodegradable polymer, (107) 158 Biodegradable polymers, (107) 78 Biodistribution, (107) 215, (107) 262 Biomimetic, (107) 502 Blood–brain barrier (BBB), (107) 428 Bovine, (107) 189 Bovine serum albumin, (107) 158 Brain delivery, (107) 428 BSA, (107) 112 Caco-2, (107) 143 Calcium silicate, (107) 300 Calcium-deficient hydroxyapatite, (107) 112 Cancer, (107) 43 Catalase, (107) 65 Cationic bovine serum albumin (CBSA), (107) 428 Cationic lipid, (107) 276 Cationic liposome, (107) 373 Cationic steroids, (107) 174
doi:10.1016/S0168-3659(05)00461-X
Cationized gelatin microspheres, (107) 547 Cavitation, (107) 484 Cavitation events, (107) 253 Cell encapsulation, (107) 395 Cell viability, (107) 65 Cellular distribution, (107) 373 Cetyltrimethylammonium bromide, (107) 357 Chemical stability, (107) 495 Chewing gum, (107) 122 Cholesterol, (107) 502 Clay mineral, (107) 408 Clozapine, (107) 215 Coating material, (107) 343 Colloidal drug carriers, (107) 229 Composite film, (107) 343 Conjugation, (107) 43 Contrast variation, (107) 244 Controlled release, (107) 449, (107) 463, (107) 547 6-Coumarin, (107) 428 Crystallization in emulsions, (107) 229 Cubic gel, (107) 495 h-cyclodextrin, (107) 158 Cystic fibrosis, (107) 537 Cytokine delivery, (107) 189 Cytotoxicity, (107) 143 Degradable hydrogel, (107) 547 Delivery systems, (107) 1 Diabetes, (107) 65 Diffusion, (107) 320 Diffusion coefficient, (107) 97 Diffusion experiments, (107) 495 Disc formation, (107) 131 Dispersion stability, (107) 408 d,l-PLGA50, (107) 53 DNA transfection, (107) 97 DNA vaccine, (107) 357 DNA vaccines, (107) 1 Doxorubicin, (107) 253, (107) 262 Drug delivery, (107) 97, (107) 502 Drug delivery system, (107) 408 Drug release, (107) 320, (107) 513
580
Subject Index Volume 107 (2005)
Drug release mechanism, (107) 131 Drug-targeting, (107) 288 Dry emulsion, (107) 91 Emulsion solvent diffusion method, (107) 300 Enteric-coating, (107) 91 Facial amphiphiles, (107) 174 Finite dissolution rate, (107) 320 Floating controlled drug delivery system, (107) 300 Fludarabine, (107) 143 Fluorescence measurements, (107) 253 Folate vector, (107) 143 Fractal dimension, (107) 203 GelucireR, (107) 523 Gene delivery, (107) 547, (107) 562 Gene transfer, (107) 174 Genetic vaccination, (107) 449 Gentamicin, (107) 463 Glutamic acid decarboxylase, (107) 562 Grafted polymer, (107) 203 HBsAg, (107) 357 Hepatitis B virus, (107) 357 His-tag, (107) 97 Huperzine A, (107) 417 Immunogenicity, (107) 357 In vitro and in vivo release, (107) 122 In vitro controlled release, (107) 53 In vitro degradation, (107) 53 Inflammation, (107) 395 In-situ process, (107) 112 Interferon-gamma, (107) 189 Intracellular delivery, (107) 262 g-irradiation, (107) 78 Islet cell targeting, (107) 562 Isoniazid, (107) 288 Isopropyl myristate (IPM), (107) 30 Ketoprofen, (107) 395 Lactosylated polyethylenimine, (107) 537 Lateral phase separation, (107) 131 Lysolipid retention, (107) 131 Magnesium aluminum silicate, (107) 343 Mathematical model, (107) 320 Matrix systems, (107) 320 Matrix-in-cylinder system, (107) 523 MCF-7, (107) 143 Melittin, (107) 310 2-Methacryloyloxyethyl phosphorylcholine, (107) 502 Microcapsule, (107) 91 Microcomposite, (107) 343
Microencapsulation, (107) 449 Microparticle, (107) 288 Microsphere, (107) 53 Microspheres, (107) 65, (107) 78, (107) 300, (107) 417, (107) 463 Nanocapsules, (107) 244 Nano-carrier, (107) 112 Nanogel, (107) 143 Nanoparticles, (107) 158, (107) 203 NFnB, (107) 373 NFnB decoy, (107) 373 Non-viral gene delivery, (107) 449 Nucleoside 5V-triphosphate, (107) 143 Octreotide acetate, (107) 474 Oral protein delivery, (107) 91 Ovalbumin, (107) 78 Paclitaxel, (107) 30 PCL-b-d,l-PLGA50, (107) 53 Pegylated nanoparticle, (107) 428 Peptide release, (107) 474 Pharmacokinetics, (107) 215 Phase transition temperature and SNALP, (107) 276 PHBV, (107) 463 Plasmid DNA, (107) 547 PLGA nanoparticles, (107) 30 Pluronic micelles, (107) 253 Poly (lactide), (107) 474 Polycaprolactone, (107) 330 Poly(d,l-lactide), (107) 244 Polyesters, (107) 395 Poly(ethylene glycol), (107) 78, (107) 408 Polyethylene glycol, (107) 43 Polyethylenimine, (107) 537 Poly-(lactic/glycolic) acid, (107) 449 Polylactide, (107) 158 Poly(lactide-co-glycolide), (107) 78 Poly(lactide-co-glycolide-acid) microparticle, (107) 357 Polymorphic transitions, (107) 229 Porcine skin, (107) 495 Porosity, (107) 203 Propranolol, (107) 523 Protein crystallization, (107) 97 Protein delivery system, (107) 158 Protein pharmaceuticals, (107) 91 PRP, (107) 330 Pulmonary immunization, (107) 1 Recombinant bacterial vector, (107) 189 Release, (107) 203 Release behaviors, (107) 112 Repaglinide, (107) 300 RGD mimetic, (107) 262 RNA interference, (107) 276
Subject Index Volume 107 (2005) SANS, (107) 244 SBF, (107) 330 Shell thickness, (107) 244 siRNA delivery, (107) 276 Skin, (107) 484 Sodium alginate, (107) 343 Sodium lauryl sulfate, (107) 484 Solid lipid nanoparticles, (107) 215, (107) 229 Spray drying, (107) 417 Stability, (107) 122 Stereocomplex, (107) 474 Sterically stabilized liposomes, (107) 262 Superoxide dismutase, (107) 65 Sustained release, (107) 189, (107) 408, (107) 523 Sustained-release, (107) 288
Thermosensitive liposomes, (107) 131 TNFa, (107) 373 a-tocopheryl succinate, (107) 43 Transcription, (107) 537 Transdermal, (107) 484 Tricalcium phosphate, (107) 330 Triglycerides, (107) 229 Tuberculosis, (107) 288 Ultrasound, (107) 484 Unsaturated polyester, (107) 513 W1 / O / W2 emulsion-solvent evaporation technique, (107) 310 Wheat germ agglutinin (WGA), (107) 30 Wollastonite, (107) 463
581